News
ICLR
106.81
+0.10%
0.11
Is ICON (NasdaqGS:ICLR) Offering An Opportunity After Recent Share Price Volatility?
Simply Wall St · 12h ago
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neogen (NEOG)
TipRanks · 3d ago
How ICON’s AI-Focused Partnership with Advarra Could Reshape ICLR’s Clinical Trial Efficiency Narrative
Simply Wall St · 4d ago
Weekly Report: what happened at ICLR last week (0330-0403)?
Weekly Report · 6d ago
A Look At ICON (ICLR) Valuation After Q1 Earnings Miss And Recent Share Price Volatility
Simply Wall St · 04/05 06:24
ICON's April Thirtieth Verdict: Can the CRO Survive Its Own Audit?
Barchart · 03/31 16:01
Weekly Report: what happened at ICLR last week (0323-0327)?
Weekly Report · 03/30 09:08
Why ICON (ICLR) Is Up 5.1% After New AI-Powered Clinical Trial Partnership With Advarra
Simply Wall St · 03/27 16:07
BMO Capital Upgrades ICON Public Limited (ICLR)
NASDAQ · 03/27 00:05
ICON raised to Outperform at BMO on valuation disconnect
Seeking Alpha · 03/26 17:10
Spotify initiated, Qualcomm downgraded: Wall Street’s top analyst calls
TipRanks · 03/26 13:50
This United Natural Foods Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Benzinga · 03/26 13:11
Arm Holdings To Rally Over 27%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga · 03/26 13:08
Icon Raised to Outperform From Market Perform by BMO Capital
Dow Jones · 03/26 12:13
Icon Price Target Raised to $130.00/Share From $100.00 by BMO Capital
Dow Jones · 03/26 12:13
BMO Capital Upgrades Icon to Outperform, Raises Price Target to $130
Benzinga · 03/26 12:03
Icon upgraded to Outperform from Market Perform at BMO Capital
TipRanks · 03/26 08:30
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Journey Medical Corp (DERM)
TipRanks · 03/26 05:00
A Look At ICON (ICLR) Valuation After New Advarra Clinical Trial Network Partnership
Simply Wall St · 03/25 11:09
Icon Plc Faces Earnings Test After Accounting Scandal and Analyst Downgrades
Barchart · 03/24 16:05
More
Webull provides a variety of real-time ICLR stock news. You can receive the latest news about ICON PLC through multiple platforms. This information may help you make smarter investment decisions.
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.